April 21, 2022 12:00 UTC TORONTO--(BUSINESS WIRE)-- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceutical company focused on progressing “Psychedelics to TherapeuticsTM”, today announced that it has partnered with Clinilabs Drug Development Corporation (“Clinilabs”), a global, full-service contract research organization with deep expertise in central nervous system drug development, to carry out the Company’s Phase 1/2a clinical trial of [...]

Pharmaceutical companies have used experimental models of transient insomnia to assess the sleep-promoting effects of investigational drugs for over 40 years.  These models have included the "first-night effect" model, a parallel-group design that assessed drug effects when sleep was recorded in normal, healthy subjects who slept in a new or novel environment for the [...]

Clinilabs congratulates Larimar Therapeutics Inc. on their Topline Phase 1 Clinical Trial Data in patients with Friedreich’s Ataxia! We are proud to have been part of this clinical trial and to have worked with this partner who is dedicated to bringing life changing treatments to patients with this rare disease. To learn more about [...]

2020 will go down as a miserable year, but beyond the heartache, some developments may represent bright spots that light the way to the future. One of these is the growth of Decentralized Clinical Trials (DCTs). DCTs are virtual trials that integrate remote assessments with modern digital health technologies, including remote rating apps, wearable monitoring [...]

T3D Therapeutics, Inc. (“T3D Therapeutics” or the “Company”), a biopharmaceutical company specializing in the development of ‘First-in-Class’ and ‘Best-in-Class’ disease-modifying, breakthrough medicine for the treatment of Alzheimer’s disease and other neurodegenerative diseases, announced it has engaged Clinilabs Drug Development Corporation (“Clinilabs”) as the contract research organization (“CRO”) for its upcoming phase 2 trial of T3D-959 named the PIONEER [...]

By now, you have likely heard about the Coronavirus (officially called “2019-Novel Coronavirus” or “COVID-19”) in the news. While the immediate health risk remains low to Americans, there are still ways that all of us can play a role in helping to prevent the spread of this and other viruses. With that said, Clinilabs, the [...]

Clinilabs Drug Development Corporation, the only global, full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug development, was engaged by a large, clinical-stage biopharmaceutical company to manage a randomized, double-blind, placebo-controlled study of a therapy for patients with acute migraine headache. The pivotal trial, involving 100 sites, various demographics and [...]

Clinilabs Drug Development Corporation, a mid-sized, full-service CRO that provides a full range of clinical drug development services, has been utilizing Facebook advertising as an essential tool for generating study participant leads with good success. In fact, Facebook recruitment has been one of Clinilabs’ fastest responding and lowest cost recruitment tools. But even with the [...]